NUPL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.338200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.161600E-01
Normal-vs-Stage2
1.545180E-01
Normal-vs-Stage3
3.479700E-02
Normal-vs-Stage4
4.729200E-01
Stage1-vs-Stage2
8.719800E-02
Stage1-vs-Stage3
6.310000E-02
Stage1-vs-Stage4
6.185800E-01
Stage2-vs-Stage3
4.877700E-02
Stage2-vs-Stage4
5.444000E-01
Stage3-vs-Stage4
5.792400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.279200E-01
Normal-vs-AfricanAmerican
2.043600E-01
Normal-vs-Asian
5.577000E-01
Caucasian-vs-AfricanAmerican
7.361800E-01
Caucasian-vs-Asian
4.982400E-01
AfricanAmerican-vs-Asian
5.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.962550E-01
Normal-vs-Female
2.998000E-01
Male-vs-Female
6.298800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.528200E-01
Normal-vs-Age(41-60Yrs)
3.537600E-01
Normal-vs-Age(61-80Yrs)
1.753820E-01
Normal-vs-Age(81-100Yrs)
2.012400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.259750E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.492500E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.093800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.378100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.936400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.852600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.407600E-02
Normal-vs-Daily Drinker
1.029170E-01
Normal-vs-Weekly Drinker
2.803800E-01
Normal-vs-Occasional Drinker
5.528800E-01
Normal-vs-Social Drinker
5.706200E-01
Non Drinker-vs-Daily Drinker
8.663400E-01
Non Drinker-vs-Weekly Drinker
6.736000E-01
Non Drinker-vs-Occasional Drinker
5.000300E-02
Non Drinker-vs-Social Drinker
1.027820E-01
Daily Drinker-vs-Weekly Drinker
6.198000E-01
Daily Drinker-vs-Occasional Drinker
6.002500E-02
Daily Drinker-vs-Social Drinker
1.161780E-01
Weekly Drinker-vs-Occasional Drinker
2.788600E-01
Weekly Drinker-vs-Social Drinker
3.825600E-01
Occasional Drinker-vs-Social Drinker
9.173200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.991200E-01
Normal-vs-Grade 2
8.892000E-01
Normal-vs-Grade 3
8.607200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.298170E-01
Grade 1-vs-Grade 3
2.682600E-01
Grade 1-vs-Grade 4
4.991200E-01
Grade 2-vs-Grade 3
5.537800E-01
Grade 2-vs-Grade 4
8.892000E-01
Grade 3-vs-Grade 4
8.607200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.379700E-02
Normal-vs-NonDiabetic
2.879600E-01
Diabetic-vs-NonDiabetic
4.190300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.049620E-01
Normal-vs-NoPancreatitis
2.223600E-01
Pancreatitis-vs-NoPancreatitis
5.816200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.518400E-01
Normal-vs-N1
1.863440E-01
N0-vs-N1
8.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.047400E-01
Normal-vs-TP53-NonMutant
6.335200E-01
TP53-Mutant-vs-TP53-NonMutant
4.588600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
